Loss of bronchoprotection to Salbutamol during sputum induction with hypertonic saline: implications for asthma therapy-Reference-Cited by-同舟云学术

Loss of bronchoprotection to Salbutamol during sputum induction with hypertonic saline: implications for asthma therapy

Published:2018-05-10 Issue:1 Volume:14 Page:
ISSN:1710-1492
Container-title:Allergy, Asthma & Clinical Immunology
language:en
Short-container-title:Allergy Asthma Clin Immunol

Author:

Wang Hongyu,Kjarsgaard Melanie,Ho Terence,Brannan John D.,Nair Parameswaran^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s13223-018-0256-7.pdf

Reference16 articles.

1. Vlachos-Mayer H, Leigh R, Sharon RF, Hussack P, Hargreave FE. Success and safety of sputum induction in the clinical setting. Eur Respir J. 2000;16(5):997–1000.

2. ten Brinke A, de Lange C, Zwinderman AH, Rabe KF, Sterk PJ, Bel EH. Sputum induction in severe asthma by a standardized protocol. Am J Respir Crit Care Med. 2001;164(5):749–53.

3. Barnes PJ. Beta-adrenergic receptors and their regulation. Am J Respir Crit Care Med. 1995;152(3):838–60.

4. Haney S, Hancox RJ. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial. Respir Res. 2005;6(1):1–7.

5. Jabbal S, Manoharan A, Lipworth BJ. Bronchoprotective tolerance with indacaterol is not modified by concomitant tiotropium in persistent asthma. Clin Exp Allergy. 2017;163:44–7.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drugs that act on the respiratory tract;Side Effects of Drugs Annual;2019